Rare Tumor
BO41932
Official Title: TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL
Study Purpose: To explore a diverse range of both investigational and off-label FDA-approved drugs, each targeting a unique mutation.
Status:
Recruiting